ストックスクリーナーアプリを入手
20.59
1.03%
0.21
アフターアワーズ：
20.59
前日終値:
$20.38
開ける：
$20.44
24時間の取引高:
814.35K
Relative Volume:
0.60
時価総額：
$2.52B
収益：
$460.48M
当期純損益:
$142.80M
株価収益率:
17.45
EPS:
1.18
ネットキャッシュフロー:
$221.79M
1週間 パフォーマンス:
-2.32%
1か月 パフォーマンス:
-2.02%
6か月 パフォーマンス:
-4.94%
1年 パフォーマンス:
+3.05%
1日の値動き範囲:
$20.39
$20.66
1週間の範囲:
$19.83
$21.82
52週間の値動き範囲:
$19.00
$26.58
Catalyst Pharmaceuticals Inc Stock (CPRX) Company Profile
名前
Catalyst Pharmaceuticals Inc
セクター
電話
(305) 529-2522
住所
355 ALHAMBRA CIRCLE, CORAL GABLES
CPRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CPRX
Catalyst Pharmaceuticals Inc
|
20.59 | 2.49B | 460.48M | 142.80M | 221.79M | 1.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Catalyst Pharmaceuticals Inc Stock (CPRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-04 | 開始されました | Robert W. Baird | Outperform |
| 2024-11-18 | 開始されました | Stephens | Overweight |
| 2024-03-14 | 開始されました | Citigroup | Buy |
| 2024-03-07 | 開始されました | BofA Securities | Buy |
| 2023-12-21 | 開始されました | Oppenheimer | Outperform |
| 2022-08-24 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2018-09-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-09-07 | 再開されました | Piper Jaffray | Overweight |
| 2016-10-05 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2016-04-26 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2014-09-30 | 繰り返されました | ROTH Capital | Buy |
| 2014-09-16 | 繰り返されました | ROTH Capital | Buy |
| 2014-09-15 | 繰り返されました | H.C. Wainwright | Buy |
| 2013-10-21 | 繰り返されました | Aegis Capital | Buy |
| 2013-09-24 | 開始されました | Maxim Group | Buy |
| 2013-09-06 | 繰り返されました | Aegis Capital | Buy |
| 2013-04-18 | 開始されました | Aegis Capital | Buy |
| 2012-08-27 | アップグレード | Rodman & Renshaw | Mkt Perform → Mkt Outperform |
| 2009-10-01 | アップグレード | Merriman | Sell → Neutral |
| 2009-05-29 | ダウングレード | Hapoalim | Neutral → Underperform |
| 2009-05-29 | ダウングレード | Merriman Curhan Ford | Buy → Sell |
| 2008-12-15 | 開始されました | Merriman Curhan Ford | Buy |
| 2007-11-28 | 開始されました | Rodman & Renshaw | Mkt Outperform |
| 2007-01-31 | 開始されました | Stifel Nicolaus | Buy |
| 2007-01-05 | 開始されました | First Albany | Buy |
すべてを表示
Catalyst Pharmaceuticals Inc (CPRX) 最新ニュース
Is Catalyst Pharmaceuticals Inc. gaining market shareWeekly Trade Review & Reliable Entry Point Alerts - خودرو بانک
Does Catalyst Pharmaceuticals Inc. have pricing powerJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - خودرو بانک
Using data models to predict Catalyst Pharmaceuticals Inc. stock movementWeekly Loss Report & Free Low Drawdown Momentum Trade Ideas - Newser
Should you wait for a breakout in Catalyst Pharmaceuticals Inc.Oil Prices & AI Forecast Swing Trade Picks - Newser
News impact scoring models applied to Catalyst Pharmaceuticals Inc.Bull Run & Risk Controlled Stock Pick Alerts - Newser
Detecting support and resistance levels for Catalyst Pharmaceuticals Inc.July 2025 Price Swings & Daily Chart Pattern Signal Reports - Newser
Statistical indicators supporting Catalyst Pharmaceuticals Inc.’s strengthPortfolio Growth Summary & Low Drawdown Trading Techniques - Newser
Market reaction to Catalyst Pharmaceuticals Inc.’s recent newsBreakout Watch & Real-Time Buy Signal Alerts - Newser
Is Catalyst Pharmaceuticals Inc. building a consolidation baseJuly 2025 Review & Technical Buy Zone Confirmation - Newser
Will Catalyst Pharmaceuticals Inc. price bounce be sustainableGap Up & Growth Focused Stock Reports - Newser
How to monitor Catalyst Pharmaceuticals Inc. with trend dashboards2025 Market Sentiment & Free High Accuracy Swing Entry Alerts - Newser
Published on: 2025-08-30 22:54:38 - beatles.ru
Short Interest Drops in Catalyst Pharmaceuticals Inc. After RallyJuly 2025 Sentiment & Safe Capital Growth Stock Tips - beatles.ru
Catalyst Pharmaceuticals Secures Exclusivity for FIRDAPSE Until 2035 - AInvest
Catalyst Pharmaceuticals Inc. stock trendline breakdownMarket Rally & Weekly Top Stock Performers List - Newser
Risk vs reward if holding onto Catalyst Pharmaceuticals Inc.Earnings Trend Report & Free Low Drawdown Momentum Trade Ideas - Newser
Identifying reversal signals in Catalyst Pharmaceuticals Inc.July 2025 Levels & Low Risk Entry Point Guides - Newser
What is Catalyst Pharmaceuticals Inc. s 5 year growth outlookTrade Risk Assessment & Daily Stock Momentum Reports - sundaytimes.kr
Catalyst Pharmaceuticals Inc. stock prediction for this weekTrade Analysis Report & Momentum Based Trading Ideas - Newser
Strategies to average down on Catalyst Pharmaceuticals Inc.Weekly Profit Recap & AI Driven Price Forecasts - Newser
Should you hold or exit Catalyst Pharmaceuticals Inc. nowJobs Report & AI Forecast Swing Trade Picks - Newser
Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
How to recover losses in Catalyst Pharmaceuticals Inc. stockPortfolio Update Summary & Free Fast Gain Swing Trade Alerts - Newser
Heatmap analysis for Catalyst Pharmaceuticals Inc. and competitors2025 Price Momentum & Short-Term Swing Trade Alerts - Newser
Catalyst Pharmaceuticals CEO Richard Daly Trades $473K in Company Stock - AInvest
Catalyst Pharmaceutical (CPRX) is a Strong Value Stock - AInvest
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock - Yahoo Finance
Catalyst Pharmaceuticals, Inc. (CPRX) Secures FIRDAPSE Market Exclusivity Until 2035 - Insider Monkey
Catalyst Pharmaceuticals Q2 Earnings Beat, Firdapse Revenues Rise Y/Y - MSN
Aug Mood: Is Catalyst Pharmaceuticals Inc. impacted by rising ratesWeekly Risk Report & Fast Gain Swing Alerts - kpenews.com
Risk adjusted return profile for Catalyst Pharmaceuticals Inc. analyzedTrade Ideas & Real-Time Chart Breakout Alerts - Newser
Catalyst Pharmaceuticals Inc (CPRX) 財務データ
収益
当期純利益
現金流量
EPS
Catalyst Pharmaceuticals Inc (CPRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Tierney David S | Director |
Aug 27 '25 |
Sale |
20.20 |
26,000 |
525,200 |
379,620 |
| Miller Steve | Chief Op. & Scientific Officer |
Aug 26 '25 |
Option Exercise |
2.24 |
115,000 |
257,600 |
1,064,663 |
| Miller Steve | Chief Op. & Scientific Officer |
Aug 27 '25 |
Option Exercise |
2.24 |
110,000 |
246,400 |
1,059,663 |
| Miller Steve | Chief Op. & Scientific Officer |
Aug 26 '25 |
Sale |
20.28 |
115,000 |
2,332,200 |
949,663 |
| Daly Richard J | President and CEO |
Aug 26 '25 |
Option Exercise |
2.24 |
50,000 |
112,000 |
249,764 |
| Daly Richard J | President and CEO |
Aug 26 '25 |
Sale |
20.62 |
22,970 |
473,641 |
226,794 |
0.96%
1.09%
大文字化:
|
ボリューム (24 時間):